UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Gene therapy, 2000-05, Vol.7 (10), p.867-874

2000

Link zum Volltext

Verfügbarkeit prüfen

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Gene therapy, 2009-12, Vol.16 (12), p.1477-1482

2009

Link zum Volltext

Verfügbarkeit prüfen

Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain

Gene therapy, 2005-04, Vol.12 (8), p.647-654

2005

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

Gene therapy, 2010-06, Vol.17 (6), p.805-810

2010

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Neuro-oncology (Charlottesville, Va.), 2012-02, Vol.14 (2), p.132-144

2012

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic viral therapies - the clinical experience

Oncogene, 2005-11, Vol.24 (52), p.7802-7816

2005

Link zum Volltext

Verfügbarkeit prüfen

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Cancer gene therapy, 2006-03, Vol.13 (3), p.253-265

2006

Link zum Volltext

Verfügbarkeit prüfen

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Human gene therapy, 1999-11, Vol.10 (17), p.2741-2755

1999

Link zum Volltext

Verfügbarkeit prüfen

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

Nature medicine, 2001-07, Vol.7 (7), p.781-787

2001

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Cancer gene therapy, 2009-07, Vol.16 (7), p.551-560

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Gene therapy, 1999-10, Vol.6 (10), p.1751-1758

1999

Link zum Volltext

Verfügbarkeit prüfen

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Human gene therapy, 1999-09, Vol.10 (13), p.2237-2243

1999

Link zum Volltext

Verfügbarkeit prüfen

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

Science (American Association for the Advancement of Science), 1991-05, Vol.252 (5007), p.854-856

1991

Link zum Volltext

Verfügbarkeit prüfen

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine

Gene therapy, 2001-02, Vol.8 (4), p.332-339

2001

Link zum Volltext

Verfügbarkeit prüfen

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Cancer gene therapy, 2013-01, Vol.20 (1), p.17-24

2013

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (11), p.6396-6401

2001

Link zum Volltext

Verfügbarkeit prüfen

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Gene therapy, 1999-04, Vol.6 (4), p.564-572

1999

Link zum Volltext

Verfügbarkeit prüfen

Neurofibromatosis 2

The New England journal of medicine, 1988-03, Vol.318 (11), p.684-688

1988

Link zum Volltext

Verfügbarkeit prüfen

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4752-4756

1995

Link zum Volltext

Verfügbarkeit prüfen

Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme

Journal of neurosurgery, 1992-08, Vol.77 (2), p.295

1992

Link zum Volltext

Verfügbarkeit prüfen

Molecular Genetic Approach to Human Meningioma: Loss of Genes on Chromosome 22

Proceedings of the National Academy of Sciences - PNAS, 1987-08, Vol.84 (15), p.5419-5423

1987

Link zum Volltext

Verfügbarkeit prüfen

Frequent loss of chromosome 14 in atypical and malignant meningioma : identification of a putative 'tumor progression' locus

Oncogene, 1997-02, Vol.14 (5), p.611-616

1997

Link zum Volltext

Verfügbarkeit prüfen

Preclinical safety evaluation of g207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

Human gene therapy, 2001-05, Vol.12 (8), p.999-1010

2001

Link zum Volltext

Verfügbarkeit prüfen

An experimental model of retrovirus gene therapy for malignant brain tumors

Journal of neurosurgery, 1993-07, Vol.79 (1), p.104

1993

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional targeting of herpes simplex virus for cell-specific replication

Journal of Virology, 1997-07, Vol.71 (7), p.5124-5132

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(167)

Publikationsform

Artikel
(207)
Buchkapitel
(1)

Sprache

Englisch
(207)
Japanisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(126)
Humans
(124)
Biological And Medical Sciences
(103)
Medical Sciences
(83)
Animals
(80)
Female
(62)
Male
(57)
Mice
(57)
Neurosciences & Neurology
(52)
Tumors
(44)
Neurology
(42)
Clinical Neurology
(39)
Tumors Of The Nervous System. Phacomatoses
(36)
Oncology
(34)
Genetics & Heredity
(32)
Surgery
(31)
Mice, Nude
(30)
Adult
(28)
Medicine, Research & Experimental
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures

Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer

Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells

Oncolytic viral therapies - the clinical experience

Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine

Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models

Oncolytic Herpes Simplex Virus Vector with Enhanced MHC Class I Presentation and Tumor Cell Killing

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

Neurofibromatosis 2

Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1

Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme

Molecular Genetic Approach to Human Meningioma: Loss of Genes on Chromosome 22

Frequent loss of chromosome 14 in atypical and malignant meningioma : identification of a putative 'tumor progression' locus

Preclinical safety evaluation of g207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

An experimental model of retrovirus gene therapy for malignant brain tumors

Transcriptional targeting of herpes simplex virus for cell-specific replication

Suchergebnisse filtern